HomeCompareAMGN vs TGT

AMGN vs TGT: Dividend Comparison 2026

AMGN yields 2.77% · TGT yields 3.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TGT wins by $4.79M in total portfolio value
10 years
AMGN
AMGN
● Live price
2.77%
Share price
$349.00
Annual div
$9.66
5Y div CAGR
48.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$164.2K
Annual income
$69,743.86
Full AMGN calculator →
TGT
TGT
● Live price
3.82%
Share price
$118.75
Annual div
$4.54
5Y div CAGR
68.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.96M
Annual income
$3,876,267.92
Full TGT calculator →

Portfolio growth — AMGN vs TGT

📍 TGT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMGNTGT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMGN + TGT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMGN pays
TGT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMGN
Annual income on $10K today (after 15% tax)
$235.27/yr
After 10yr DRIP, annual income (after tax)
$59,282.28/yr
TGT
Annual income on $10K today (after 15% tax)
$324.97/yr
After 10yr DRIP, annual income (after tax)
$3,294,827.73/yr
At 15% tax rate, TGT beats the other by $3,235,545.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMGN + TGT for your $10,000?

AMGN: 50%TGT: 50%
100% TGT50/50100% AMGN
Portfolio after 10yr
$2.56M
Annual income
$1,973,005.89/yr
Blended yield
77.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on TGT right now

AMGN
Analyst Ratings
22
Buy
13
Hold
3
Sell
Consensus: Buy
Price Target
$347.73
-0.4% upside vs current
Range: $185.00 — $432.00
Altman Z
2.3
Piotroski
8/9
TGT
Analyst Ratings
27
Buy
28
Hold
4
Sell
Consensus: Hold
Price Target
$114.06
-3.9% upside vs current
Range: $81.00 — $145.00
Altman Z
3.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMGN buys
0
TGT buys
0
No recent congressional trades found for AMGN or TGT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMGNTGT
Forward yield2.77%3.82%
Annual dividend / share$9.66$4.54
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR48.6%68.5%
Portfolio after 10y$164.2K$4.96M
Annual income after 10y$69,743.86$3,876,267.92
Total dividends collected$133.8K$4.84M
Payment frequencyquarterlyquarterly
SectorHealthcareConsumer Staples
Analyst consensusBuyHold
Analyst price target$347.73$114.06

Year-by-year: AMGN vs TGT ($10,000, DRIP)

YearAMGN PortfolioAMGN Income/yrTGT PortfolioTGT Income/yrGap
1← crossover$11,111$411.31$11,344$644.20$233.00TGT
2$12,524$634.70$13,289$1,150.83$765.00TGT
3$14,394$993.52$16,342$2,123.00$1.9KTGT
4$16,987$1,585.83$21,598$4,111.36$4.6KTGT
5$20,776$2,599.19$31,666$8,556.46$10.9KTGT
6$26,645$4,414.70$53,638$19,755.86$27.0KTGT
7$36,373$7,863.06$110,091$52,698.15$73.7KTGT
8$53,826$14,907.12$288,127$170,328.82$234.3KTGT
9$88,231$30,636.84$1,010,291$701,995.64$922.1KTGT
10$164,151$69,743.86$4,957,279$3,876,267.92$4.79MTGT

AMGN vs TGT: Complete Analysis 2026

AMGNHealthcare

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Full AMGN Calculator →

TGTConsumer Staples

Target Corporation operates as a general merchandise retailer in the United States. The company offers food assortments, including perishables, dry grocery, dairy, and frozen items; apparel, accessories, home décor products, electronics, toys, seasonal offerings, food, and other merchandise; and beauty and household essentials. It also provides in-store amenities, such as Target Café, Target Optical, Starbucks, and other food service offerings. The company sells its products through its stores; and digital channels, including Target.com. As of March 09, 2022, the company operated approximately 2,000 stores. Target Corporation was incorporated in 1902 and is headquartered in Minneapolis, Minnesota.

Full TGT Calculator →
📬

Get this AMGN vs TGT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMGN vs SCHDAMGN vs JEPIAMGN vs OAMGN vs KOAMGN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.